Medicinal plants as sources of active molecules against COVID-19
B Benarba, A Pandiella - Frontiers in pharmacology, 2020 - frontiersin.org
The Severe Acute Respiratory Syndrome-related Coronavirus 2 (SARS-CoV-2) or novel
coronavirus (COVID-19) infection has been declared world pandemic causing a worrisome …
coronavirus (COVID-19) infection has been declared world pandemic causing a worrisome …
Plants metabolites: possibility of natural therapeutics against the COVID-19 pandemic
COVID-19, a disease induced by SARS-CoV-2 (Severe Acute Respiratory Syndrome
Coronavirus-2), has been the cause of a worldwide pandemic. Though extensive research …
Coronavirus-2), has been the cause of a worldwide pandemic. Though extensive research …
In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19
Virtual screening of phytochemicals was performed through molecular docking, simulations,
in silico ADMET and drug-likeness prediction to identify the potential hits that can inhibit the …
in silico ADMET and drug-likeness prediction to identify the potential hits that can inhibit the …
Promising antiviral activities of natural flavonoids against SARS-CoV-2 targets: systematic review
The ongoing COVID-19 pandemic, caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) became a globally leading public health concern over the past …
coronavirus 2 (SARS-CoV-2) became a globally leading public health concern over the past …
Botanical drugs and supplements affecting the immune response in the time of COVID‐19: Implications for research and clinical practice
In times of health crisis, including the current COVID‐19 pandemic, the potential benefit of
botanical drugs and supplements emerges as a focus of attention, although controversial …
botanical drugs and supplements emerges as a focus of attention, although controversial …
[HTML][HTML] Calendulaglycoside A showing potential activity against SARS-CoV-2 main protease: Molecular docking, molecular dynamics, and SAR studies
Background and aim The discovery of drugs capable of inhibiting SARS-CoV-2 is a priority
for human beings due to the severity of the global health pandemic caused by COVID-19. To …
for human beings due to the severity of the global health pandemic caused by COVID-19. To …
[HTML][HTML] In-silico evaluation of bioactive compounds from tea as potential SARS-CoV-2 nonstructural protein 16 inhibitors
R Singh, VK Bhardwaj, J Sharma, R Purohit… - Journal of traditional and …, 2022 - Elsevier
Background and aim A novel coronavirus, called the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has been found to cause COVID-19 in humans and some …
coronavirus 2 (SARS-CoV-2) has been found to cause COVID-19 in humans and some …
[HTML][HTML] Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach
P Rangsinth, C Sillapachaiyaporn, S Nilkhet… - Journal of traditional and …, 2021 - Elsevier
Abstract Background and aim Coronavirus Disease 2019 (COVID-19) caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has now become the world …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has now become the world …
[HTML][HTML] Will curcumin nanosystems be the next promising antiviral alternatives in COVID-19 treatment trials?
D Dourado, DT Freire, DT Pereira… - Biomedicine & …, 2021 - Elsevier
The COVID-19 has become of striking interest since the number of deaths is constantly
rising all over the globe, and the search for an efficient treatment is more urgent. In light of …
rising all over the globe, and the search for an efficient treatment is more urgent. In light of …
An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment
AD Fuzimoto - Journal of integrative medicine, 2021 - Elsevier
Artemisia annua and its phytocompounds have a rich history in the research and treatment
of malaria, rheumatoid arthritis, systemic lupus erythematosus, and other diseases …
of malaria, rheumatoid arthritis, systemic lupus erythematosus, and other diseases …